Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
31
IGMS Quote, Financials, Valuation and Earnings
Last price:
$1.28
Seasonality move
:
28.2%
Day range:
$1.26 - $1.36
52-week range:
$0.92 - $22.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
28.79x
P/B ratio:
109.38x
Volume:
1.8M
Avg. volume:
908.9K
1-year change:
-89.15%
Market cap:
$76.3M
Revenue:
$2.7M
EPS (TTM):
-$3.27
Earnings Data
Next earnings date for IGMS
Aug 14
2025
Most recent earnings per share
-$0.86
Missed by $0.41
(May 13/2025)
Consensus Estimate
-$0.45
(May 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IGMS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $3.2M | -- | -- | -- | -- |
| 08/14/2025 | Q2 | $3.2M | -- | -- | -- | -- |
| 05/13/2025 | Q1 | $4.3M | $499K | -$0.86 | -$0.45 | -$0.41 |
| 03/14/2025 | Q4 | $393.8K | $412K | -$0.61 | -$0.71 | $0.10 |
| 11/08/2024 | Q3 | $242.2K | $516K | -$1.01 | -$0.80 | -$0.21 |
| 08/14/2024 | Q2 | $54.3M | $1.3M | -$0.79 | -$0.04 | -$0.75 |
| 05/08/2024 | Q1 | $759.4K | $497K | -$0.83 | -$0.85 | $0.02 |
| 03/07/2024 | Q4 | $766.3K | $651K | -$0.98 | -$1.09 | $0.11 |
| 11/13/2023 | Q3 | -- | -- | -$1.04 | -$1.22 | $0.18 |
| 08/03/2023 | Q2 | -- | -- | -$1.43 | -$1.44 | $0.01 |
| 05/12/2023 | Q1 | -- | -- | -$1.33 | -$1.36 | $0.03 |
| 03/30/2023 | Q4 | -- | -- | -$1.19 | -$1.03 | -$0.16 |
| 11/03/2022 | Q3 | -- | -- | -$1.32 | -$1.49 | $0.17 |
| 08/08/2022 | Q2 | -- | -- | -$1.33 | -$0.48 | -$0.85 |
| 05/09/2022 | Q1 | -- | -- | -$1.53 | -$1.62 | $0.09 |
| 03/29/2022 | Q4 | -- | -- | -$1.50 | -$1.53 | $0.03 |
| 11/04/2021 | Q3 | -- | -- | -$1.32 | -$1.42 | $0.10 |
| 08/09/2021 | Q2 | -- | -- | -$1.16 | -$1.18 | $0.02 |
| 05/06/2021 | Q1 | -- | -- | -$0.95 | -$0.95 | -- |
| 03/30/2021 | Q4 | -- | -- | -$0.79 | -$0.82 | $0.03 |
| 11/05/2020 | Q3 | -- | -- | -$0.66 | -$0.66 | $0.00 |
| 08/06/2020 | Q2 | -- | -- | -$0.62 | -$0.63 | $0.01 |
| 05/07/2020 | Q1 | -- | -- | -$0.58 | -- | -- |
| 03/26/2020 | Q4 | -- | -- | -$0.49 | -- | -- |
| 11/07/2019 | Q3 | -- | -- | -$2.41 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -- | -- | -- |
IGM Biosciences Earnings Questions
-
How Much did IGM Biosciences Generate in Revenue Last Quarter?
IGM Biosciences reported $499K worth of top line sales in its most recent quarter.
-
Did IGM Biosciences Beat Earnings Last Quarter?
IGM Biosciences announced earnings per share of -$0.86 which represents a miss of analyst forecast a -$0.45 per share.
-
Is IGM Biosciences Profitable?
IGM Biosciences reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for IGM Biosciences EPS Next Year?
IGM Biosciences's earnings are forecast to decrease from -$3.24 per share to -$3.34 per share next year representing a decrease of -62.96%.
-
When is IGM Biosciences's Earnings Date?
IGM Biosciences's next earnings date is August 14, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
